Growth Metrics

Neurocrine Biosciences (NBIX) Finished Goods: 2017-2020

Historic Finished Goods for Neurocrine Biosciences (NBIX) over the last 1 years, with Dec 2020 value amounting to $9.0 million.

  • Neurocrine Biosciences' Finished Goods rose 429.41% to $9.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $9.0 million, marking a year-over-year increase of 429.41%. This contributed to the annual value of $9.0 million for FY2020, which is 429.41% up from last year.
  • As of Q4 2020, Neurocrine Biosciences' Finished Goods stood at $9.0 million, which was up 291.30% from $2.3 million recorded in Q1 2020.
  • Neurocrine Biosciences' 5-year Finished Goods high stood at $9.0 million for Q4 2020, and its period low was $533,000 during Q4 2017.
  • Moreover, its 3-year median value for Finished Goods was $1.8 million (2019), whereas its average is $2.5 million.
  • Data for Neurocrine Biosciences' Finished Goods shows a peak YoY soared of 429.41% (in 2020) over the last 5 years.
  • Over the past 4 years, Neurocrine Biosciences' Finished Goods (Quarterly) stood at $533,000 in 2017, then soared by 50.28% to $801,000 in 2018, then skyrocketed by 112.23% to $1.7 million in 2019, then spiked by 429.41% to $9.0 million in 2020.
  • Its Finished Goods was $9.0 million in Q4 2020, compared to $2.3 million in Q1 2020 and $1.7 million in Q4 2019.